SEARCH
Enter your search term below:
Close
Enter your search term below:
WORLD LEADING BUSINESS SUPPORT
That was the focus of the latest SETsquared Innovation Insights session, which explored how the Deal Readiness Toolkit is being used across the university commercialisation landscape. Hosted by Diana Galpin, Enterprise & Knowledge Exchange, University of Southampton and Director & Management Board Member on SETsquared, the discussion brought together Andrew Wilson, RTTP, Head of Commercialisation at the University of Bristol; David Woolley, Head of Technology Transfer and IP at the University of Southampton; Nathan Guest, Corporate Partner at VWV; and Dr Arne Scott, CEO and Co-Founder of Dimension Biotechnologies.
A starting point for better deals
The Toolkit was funded by Research England and developed by the SETsquared Partnership and provides practical guidance on the journey from the decision to commercialise intellectual property (IP) through to completing a deal. It is designed to support technology transfer professionals, academic founders, investors and licensees.
Co-created with SETsquared universities, investors, law firms, patent attorneys and other organisations, the Toolkit brings together 14 core resources. These include separate spin-out and licensing pathways, process maps, legal templates, checklists and playbooks explaining key steps, terminology and commercial considerations.
The Toolkit complements existing guidance, such as the University Spin-out Investment Terms (USIT) guides, by helping users understand and navigate the practical steps involved in a deal. Users can explore an entire commercialisation pathway or go directly to the resource they need, with guidance organised around different roles and stages: preparation, negotiation and deal completion.
More than 700 people have now used the Toolkit. It has also been highlighted in the UKRI IP strategic statement and in Tony Hickson’s Deeping University-Investor Links report on deepening links between universities and investors. The next challenge is to build on that awareness and encourage wider adoption across the commercialisation ecosystem.
Consistency that builds confidence
For university technology transfer offices, one of the most immediate benefits is having documents that work together. At the University of Bristol, Andrew Wilson explained that previous agreements had developed over time and were not always as coherent as they could be. The Toolkit provides a more consistent approach: “They’re all coherent. So, what goes in the term sheet is reflected in the license, and the spin-out term sheet is then reflected in what’s in the spin-out agreements. It’s a big part of why we’re implementing it.”
David Woolley described a similar benefit at Southampton, where the Toolkit is used by team members with different levels of experience. “I do like the fact that it’s very flexible. You can go to a particular document just to see industry sector best practice for a license agreement or shareholders agreement, or you can investigate an entire pathway description.” Flowcharts and checklists are useful safeguards, particularly when busy teams are managing several commercialisation projects at once.
The Toolkit is not intended to be followed in the same way for every opportunity. Some teams use it from the earliest conversations with academics considering a spin-out; others turn to a particular template when they reach heads of terms or are preparing to complete a deal. Its combination of consistency and flexibility gives university teams and their advisers more scope to focus on the commercial decisions, rather than spending time making different documents fit together.
From a blank page to a better deal
For a founder with interested investors but no deal documents in place, knowing where to start can be a challenge. That was the position facing Dr Arne Scott at Dimension Biotechnologies, a spin-out from the University of Bristol. With angel investors not providing their own heads of terms or templates, the company needed a starting point. Scott explained what the Toolkit made possible: “The templates gave us the confidence and comfortability we needed to focus on building the company. They helped form the very legal documents that form the foundations of Dimension Biotechnologies.”
That foundation was designed to serve the company beyond its first deal. Nathan Guest, Corporate partner at VWV, was involved in Dimension’s spin-out, explained how the Toolkit builds on familiar investment documents: “We started with the UK private capital template documents, which are becoming increasingly common in UK investment deals.” As the company grows, those early agreements will come under scrutiny from larger venture capital investors and other stakeholders. Starting with a recognised structure gives the company a foundation to build on as it progresses towards future investment rounds.
Feedback from the audience also highlighted the wider value of the resources. Siobhan, from the University of Birmingham, described using the shareholders’ agreement and articles templates to adapt documents supplied by investors for a recent spin-out: “It helped clarify what needed to be included from the university’s perspective. It made the process much smoother for everybody involved.”
Familiar documents do not mean identical deals. Each transaction still requires appropriate advice and negotiation to reflect its particular circumstances. The Toolkit offers a starting point, rather than a finished agreement, helping founders and their advisers spend less time starting from scratch and more time working through what their deal needs.
The value is in understanding the detail
Templates are only part of the picture. The panel emphasised the importance of the accompanying playbooks, which explain why particular provisions appear in an agreement and what they mean for different parties involved. As Andrew Wilson observed, “If you’re faced with a blank term sheet and don’t really know what to put in it, it can be quite daunting.” He explained that the playbooks help staff get up to speed and use the templates appropriately.
This is particularly valuable for academic founders encountering investor expectations and commercial agreements for the first time. Topics such as due diligence, data rooms, non-compete and non-solicitation provisions can raise difficult questions. Nathan Guest described the balance that needs to be struck: “The university can’t be in a situation where it has got academics who are contractually prevented from doing the thing that the university pays them for. Equally, the company needs to make sure that it is protected, and particularly around IP.” The playbooks aim to explain this commercial context in accessible language, helping founders understand the reasoning behind terms that might otherwise come as a surprise.
Used early, this guidance can help people ask better questions before negotiations become pressured. Andrew Wilson encouraged academics to read some of the guides, saying: “I really think it demystifies the process. It builds confidence and allows the right questions to be asked at an early stage.”
Building on what is already there
There is still scope to develop the Toolkit further, particularly in its support for social ventures, where the current legal templates do not accommodate every business structure. Its licensing resources could also be expanded to cover option and evaluation agreements, joint projects and collaborative research. However, future development is only part of the picture. As Nathan Guest highlighted, the more widely these resources are used, the greater their potential to support more consistent, collaborative and effective commercialisation across the UK.
Ultimately, the Toolkit is about more than just standardising legal documents. By giving universities, founders, investors and advisers a shared understanding of the commercialisation process, it can help build confidence, reduce uncertainty and make it easier for promising research to move towards real-world application.
For anyone involved in university innovation, whether exploring the potential of a new spin-out, negotiating a licence or supporting a researcher’s first steps into commercialisation, the SETsquared Deal Readiness Toolkit offers a practical place to start.
Get all the fresh insights first! Stay up-to-date with all the
latest investment news, blogs and all things SETsquared.
Close
Close